4506 — Sumitomo Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥164bn
- ¥533bn
- ¥556bn
- 15
- 53
- 30
- 18
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 48,627 | 35,918 | 36,829 | 40,600 | -96,714 |
Depreciation | |||||
Non-Cash Items | 33,184 | 28,869 | 52,197 | 49,850 | 87,168 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -47,076 | -36,024 | 23,902 | -97,559 | -20,915 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 48,711 | 46,128 | 135,601 | 31,239 | 10,802 |
Capital Expenditures | -12,914 | -13,351 | -10,806 | -13,494 | -12,742 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -22,135 | -299,333 | 19,681 | -4,784 | 65,161 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -35,049 | -312,684 | 8,875 | -18,278 | 52,419 |
Financing Cash Flow Items | -4 | -1,353 | -17,335 | -870 | -197,436 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -28,645 | 231,081 | -57,215 | -21,426 | -146,817 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10,479 | -35,588 | 91,990 | 9,286 | -59,506 |